NICE v world on endocarditis prophylaxis

BMJ

Volumn 342, Issue 7811, 2011, Pages

  Chambers, John B ^a   Shanson, David ^b   Venn, Graham ^a   Pepper, John ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL ENDOCARDITIS; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; LETTER; MORTALITY; NATIONAL HEALTH ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL RATE;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; ENDOCARDITIS; HUMANS;

EID: 84859006009     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d3531     Document Type: Letter

References (5)

1. Thornhill MH, Dayer MJ, Forde JM, Corey GR, Chu VH, Couper DJ, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ 2011;342:d2392. (3 May.)
2. Chambers J, Shanson D, Hall R, Venn G, Pepper J, McGurk M. Antibiotic prophylaxis of endocarditis: the rest of the world and NICE. J Roy Soc Med 2011;104:138-40.
3. Oliver R, Roberts GJ, Hooper L, Worthington HV. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev 2008;4:CD003813.
4. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007;297:1354-61. (Pubitemid 46513236)
5. Horstkotte D, Rosin H, Friedrichs W, Loogen F. Contribution for choosing the optimal prophylaxis of bacterial endocarditis. Eur Heart J 1987;8(suppl J):379-81. (Pubitemid 18057497)